Optibiotix Health Plc
Company Profile
Company website
Sector
Pharmaceuticals & Biotechnology (Biotechnology)
Description
OptiBiotix Health plc (AIM: OPTI) develops compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease.
Not all Walbrook clients have a handy 2 page summary available. Click on "Register your interest" and we'll let the Company know that you think this would be useful
Latest Company Summary
Investor Access
17
Nov
Event information
Management will hold a presentation for Investors through the digital platform, Investor Meet Company, on Thursday, 17 November 2022 at 12:00 providing an update on the commercial strategy and future plans for the Company. Investors can sign up to Investor Meet Company for free, by clicking here.
Venue
Online
Time
Thursday, 17 November 2022 at 12:00
Financial Calendar
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results* | May |
| Interim Results* | September |
| AGM* | July |
* Months based on previous announcements of this kind
